共 50 条
- [31] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialNATURE MEDICINE, 2021, 27 (10) : 1797 - +Cordoba, ShaunOnuoha, ShimobiThomas, SimonPignataro, Daniela SorianoHough, RachaelGhorashian, SaraVora, AjayBonney, DeniseVeys, PaulRao, KanchanLucchini, GiovannaChiesa, RobertChu, JanClark, LizFung, Mei MeiSmith, KovalPeticone, CarlottaAl-Hajj, MuhammadBaldan, VaniaFerrari, MathieuSrivastava, SaketJha, RamVargas, Frederick ArceDuffy, KevinDay, WilliamVirgo, PaulWheeler, LucyHancock, JeremyFarzaneh, FarzinDomning, SabineZhang, YiyunKhokhar, Nushmia Z.Peddareddigari, Vijay G. R.Wynn, RobertPule, MartinAmrolia, Persis J.
- [33] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in AdultsBLOOD, 2023, 142Tu, SanfangZhou, LijuanHuang, RuiZhou, XuanYang, JilongLi, MeifangJin, BoWang, LangqiZhuo, YaqiChen, HuifangChang, Lung-JiLi, Yuhua
- [34] Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemiaBRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 373 - 377Dourthe, Marie EmilieYakouben, KarimaDavid, AudreyThouvenin, SandrineChaillou, DelphineCaillat-Zucman, SophieCuffel, AlexisTardy, CleaLainey, ElodieCaye-Eude, AurelieArfeuille, ChloeDelaugerre, ConstanceChaix-Baudier, Marie-LaureNaudin, JeromeAuvin, StephaneBergaoui, KarimMerlat-Guitard, Anne-IsabelleDe Jorna, RomainMebarki, MiryamDalle, Jean-HuguesBaruchel, Andre
- [35] CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIAHAEMATOLOGICA, 2019, 104 : 4 - 4Caruso, S.Quintarelli, C.Sivori, S.Carlomagno, S.Falco, M.Boffa, I.Orlando, D.Guercio, M.Abbaszadeh, Z.Sinibaldi, M.Di Cecca, S.Camera, A.Cembrola, B.Bovetti, K.Pitisci, A.Andreani, M.Vinti, L.Del Bufalo, F.Algeri, M.Pira, G. LiMoseley, A.De Angelis, B.Moretta, L.Locatelli, F.
- [36] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T TherapyBLOOD, 2020, 136Yu, XinjianLi, PanFeng, HeyuanKang, JianZheng, XichangZhang, YunmeiYang, WenhongWu, TongLiu, Shuangyou
- [38] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +Myers, Regina M.Li, YimeiLeahy, Allison BarzBarrett, David M.Teachey, David T.Callahan, ColleenFasano, Christina C.Rheingold, Susan R.DiNofia, AmandaWray, LisaAplenc, RichardBaniewicz, DianeLiu, HongyanShaw, Pamela A.Pequignot, EdwardGetz, Kelly D.Brogdon, Jennifer L.Fesnak, Andrew D.Siegel, Donald L.Davis, Megan M.Bartoszek, ChelsieLacey, Simon F.Hexner, Elizabeth O.Chew, AnneWertheim, Gerald B.Levine, Bruce L.June, Carl H.Grupp, Stephan A.Maude, Shannon L.
- [39] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemiaAMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165Wang, ShiyuanWang, XueYe, ChunyingCheng, HaiShi, MingChen, WeiQi, KunmingWang, GangWu, QingyunZeng, LingyuLi, ZhenyuJing, GuangjunZheng, JunnianXu, KailinCao, Jiang
- [40] Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic LeukemiaBLOOD, 2016, 128 (22)Maude, Shannon L.Barrett, David M.Rheingold, Susan R.Aplenc, RichardTeachey, David T.Callahan, ColleenBaniewicz, DianeWhite, ClaireTalekar, Mala K.Shaw, Pamela A.Brogdon, Jennifer L.Young, Regina M.Scholler, JohnMarcucci, Katherine T.Levine, Bruce L.Frey, NoellePorter, David L.Lacey, Simon F.Melenhorst, J. JosephJune, Carl H.Grupp, Stephan A.